Xiangxue Pharmaceutical Co.,Ltd. (SHE:300147)
China · Delayed Price · Currency is CNY 4.850
+0.500 (11.49%)
Nov 5, 2026, 3:04 PM CST
Xiangxue Pharmaceutical Market Cap
Xiangxue Pharmaceutical has a market cap or net worth of 3.21 billion as of November 5, 2026. It is the 15,266th most valuable company in the world and the 4,115th biggest in China. Its market cap has decreased by 50.66% in one year.
Market Cap
3.21B
Enterprise Value
4.84B
Revenue
1.51B
Global Rank
Country Rank
#4,115 China
PE Ratio
n/a
ChartMarket Cap Chart
Since December 15, 2010, Xiangxue Pharmaceutical's market cap has decreased from 4.81B to 3.21B, a decrease of -33.31%. That is a compound annual growth rate of -2.52%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 5, 2026 | 3.21B | -46.70% |
| Dec 31, 2025 | 6.02B | -6.86% |
| Dec 31, 2024 | 6.46B | 89.71% |
| Dec 29, 2023 | 3.41B | -14.02% |
| Dec 30, 2022 | 3.96B | -24.79% |
| Dec 31, 2021 | 5.27B | -9.85% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Pulike Biological Engineering | 3.18B |
| Kexing Biopharm | 3.15B |
| Qingdao Vland Biotech INC. | 3.01B |
| Shanghai Shen Lian Biomedical | 3.00B |
| Lifecome Biochemistry | 2.88B |
| Jiangsu Bioperfectus Technologies | 2.87B |
| Guanhao Biotech | 2.86B |
| Hubei Goto Biopharm Group | 2.81B |